Lipitor
Healthy Adult Subject
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.Phase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 89/ 100
Competitive context
2 Active assets in the Healthy Adult Subject cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DYNAMOS Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Phase 1 | CC |
Rosuvastatin Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Phase 1 | CC |
Same molecule, other indications
Lipitor is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →